Intellect Neurosciences Inc. (fka ILNS)

[qotsa55]

Putting a lot on me there tmic...lol. I believe there is some value in Intellect...how much for common shareholders is uncertain. In the case of a buyout, common shareholders would only receive a percentage of what was left after everyone else from the company..Chain, Maza, BOD etc..got theirs. I think Intellect hasn't been bought out because large Pharmas know they can pick up Intellect a lot cheaper then the company wants to sell for and that's why I believe there hasn't been a sale yet. The only solid trial Intellect currently has a piece of is the one for OX1 with Shire. Ponzeumab is in dispute and even though most people seem to think Intellect wil eventually prevail (myself included) no one can ever know for sure. Plus I believe that dispute isn't anywhere near over. Pfizer will continue to fight Intellect and this will go on for at least another two years. IMO. Like I've said in the recent past here..I'm hoping for anywhere between .015 to .025 cents for common shareholders in a buyout. But the recent PR with the new financing deal makes me believe we are more likely only to see .015 max in a buyout. That is still more than a double from these levels though. This is my opinion and has been for some time now. GLTY